Based on recent data, Amneal Pharmaceuticals, Inc. (AMRX) shows an Average True Range (ATR) of 0.44 and an Enterprise Value of 4.53B. Its average trading volume over the past 3 months is 2.34M, indicating liquidity. These fundamental metrics provide insight into AMRX's underlying financial health and market activity.
| ATR | 0.44 |
| Enterprise Value | 4.53B |
| Avg Vol (3 Months) | 2.34M |
| Avg Vol (10 Days) | 2.1M |
Amneal Pharmaceuticals, Inc. (AMRX) technical indicators as of February 11, 2026: the SMA 20 is 6.41%, SMA 50 at 12.87%, and SMA 200 at 46.35%. The RSI 14 value is 69.78, suggesting its current momentum. These technical analysis signals help assess AMRX's price trends and potential future movements.
| SMA 20 | 6.41% |
| SMA 50 | 12.87% |
| SMA 200 | 46.35% |
| RSI 14 | 69.78 |
Amneal Pharmaceuticals, Inc. (AMRX) stock performance overview as of February 11, 2026: The 52-week high is $15 (currently -1.6% below), and the 52-week low is $6.68 (currently 120.79% above). Over the past year, AMRX's performance is 60.41%, compared to the S&P 500's 8.87% change.
| 52-Week High | 15 |
| 52-Week High Chg | -1.60% |
| 52-Week Low | 6.68 |
| 52-Week Low Chg | +120.79% |
| S&P 500 52-Week Chg | 8.87% |
According to market data, Amneal Pharmaceuticals, Inc. (AMRX) stock's recent performance metrics show that over the last month, AMRX is 8.11%, with a Year-to-Date (YTD) performance of 5.79%. Over the past year, the stock has seen a 60.41% change. These figures summarize AMRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 14.99 | 15 | 15 | 15 | 15 | 15 |
| Low | 14.32 | 12.66 | 11.29 | 8.5 | 6.68 | 12.33 |
| Performance | +2.70% | +8.11% | +34.38% | +68.52% | +60.41% | +5.79% |
According to current financial data, AMRX stock's P/E (TTM) ratio is 784.36, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for AMRX, including P/S (1.58), P/B (-42.28), and P/FCF (18.91), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AMRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 784.36 | -1.23 | 13.14 | 32.59 |
| P/S (TTM) | 1.58 | 3.71 | 6.11 | 5.98 |
| P/B (TTM) | -42.28 | N/A | 22.43 | 5.42 |
| P/FCF (TTM) | 18.91 | -7.37 | -2.53 | 31.77 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep